S&P 500   2,997.31 (+0.04%)
DOW   26,793.37 (+0.02%)
QQQ   191.76 (-0.05%)
AAPL   242.54 (+1.08%)
FB   185.02 (+1.46%)
MSFT   136.15 (-0.16%)
GOOGL   1,253.56 (+1.00%)
AMZN   1,760.79 (-0.28%)
NVDA   194.61 (-0.51%)
MU   44.53 (-0.29%)
BABA   168.68 (-0.71%)
GE   9.06 (-0.11%)
TSLA   254.35 (-0.48%)
T   37.80 (-1.00%)
F   9.08 (+0.11%)
ACB   3.68 (+2.80%)
NFLX   272.35 (+2.12%)
BAC   31.23 (+0.10%)
DIS   131.37 (-0.78%)
S&P 500   2,997.31 (+0.04%)
DOW   26,793.37 (+0.02%)
QQQ   191.76 (-0.05%)
AAPL   242.54 (+1.08%)
FB   185.02 (+1.46%)
MSFT   136.15 (-0.16%)
GOOGL   1,253.56 (+1.00%)
AMZN   1,760.79 (-0.28%)
NVDA   194.61 (-0.51%)
MU   44.53 (-0.29%)
BABA   168.68 (-0.71%)
GE   9.06 (-0.11%)
TSLA   254.35 (-0.48%)
T   37.80 (-1.00%)
F   9.08 (+0.11%)
ACB   3.68 (+2.80%)
NFLX   272.35 (+2.12%)
BAC   31.23 (+0.10%)
DIS   131.37 (-0.78%)
Log in

Johnson & Johnson Stock Price, News & Analysis (NYSE:JNJ)

$129.70
+0.50 (+0.39 %)
(As of 10/23/2019 02:06 PM ET)
Today's Range
$129.07
Now: $129.70
$130.48
50-Day Range
$127.58
MA: $130.47
$137.21
52-Week Range
$121.00
Now: $129.70
$148.99
Volume3.05 million shs
Average Volume8.87 million shs
Market Capitalization$342.30 billion
P/E Ratio15.86
Dividend Yield2.97%
Beta0.69
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP47816010
Phone732-524-0400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$81.58 billion
Cash Flow$11.05 per share
Book Value$22.28 per share

Profitability

Net Income$15.30 billion

Miscellaneous

Employees135,100
Outstanding Shares2,639,170,000
Market Cap$342.30 billion
Next Earnings Date1/28/2020 (Estimated)
OptionableOptionable

Receive JNJ News and Ratings via Email

Sign-up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter.


Johnson & Johnson (NYSE:JNJ) Frequently Asked Questions

What is Johnson & Johnson's stock symbol?

Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol "JNJ."

How often does Johnson & Johnson pay dividends? What is the dividend yield for Johnson & Johnson?

Johnson & Johnson declared a quarterly dividend on Thursday, October 17th. Shareholders of record on Tuesday, November 26th will be given a dividend of $0.95 per share on Tuesday, December 10th. This represents a $3.80 annualized dividend and a yield of 2.92%. The ex-dividend date of this dividend is Monday, November 25th. View Johnson & Johnson's Dividend History.

How will Johnson & Johnson's stock buyback program work?

Johnson & Johnson declared that its board has initiated a stock buyback program on Monday, December 17th 2018, which authorizes the company to buyback $5,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 1.5% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's board of directors believes its shares are undervalued.

How were Johnson & Johnson's earnings last quarter?

Johnson & Johnson (NYSE:JNJ) released its quarterly earnings data on Tuesday, October, 15th. The company reported $2.12 EPS for the quarter, topping the Zacks' consensus estimate of $2.00 by $0.12. The firm earned $20.73 billion during the quarter, compared to the consensus estimate of $20.14 billion. Johnson & Johnson had a return on equity of 39.54% and a net margin of 21.09%. The business's revenue for the quarter was up 1.9% on a year-over-year basis. During the same period in the previous year, the firm earned $2.05 EPS. View Johnson & Johnson's Earnings History.

When is Johnson & Johnson's next earnings date?

Johnson & Johnson is scheduled to release their next quarterly earnings announcement on Tuesday, January 28th 2020. View Earnings Estimates for Johnson & Johnson.

What guidance has Johnson & Johnson issued on next quarter's earnings?

Johnson & Johnson issued an update on its FY19 earnings guidance on Tuesday, October, 15th. The company provided earnings per share (EPS) guidance of $8.62-8.67 for the period, compared to the Thomson Reuters consensus estimate of $8.61. The company issued revenue guidance of $81.8-82.3 billion, compared to the consensus revenue estimate of $81.59 billion.

What price target have analysts set for JNJ?

12 brokers have issued 12-month price objectives for Johnson & Johnson's shares. Their predictions range from $140.00 to $169.00. On average, they expect Johnson & Johnson's stock price to reach $152.10 in the next twelve months. This suggests a possible upside of 17.0% from the stock's current price. View Analyst Price Targets for Johnson & Johnson.

What is the consensus analysts' recommendation for Johnson & Johnson?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Johnson & Johnson in the last year. There are currently 5 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Johnson & Johnson.

Has Johnson & Johnson been receiving favorable news coverage?

News articles about JNJ stock have trended somewhat positive on Wednesday, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Johnson & Johnson earned a media sentiment score of 0.6 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for Johnson & Johnson.

Who are some of Johnson & Johnson's key competitors?

What other stocks do shareholders of Johnson & Johnson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Johnson & Johnson investors own include AT&T (T), Verizon Communications (VZ), Cisco Systems (CSCO), Procter & Gamble (PG), Pfizer (PFE), Walt Disney (DIS), Intel (INTC), JPMorgan Chase & Co. (JPM), Exxon Mobil (XOM) and Boeing (BA).

Who are Johnson & Johnson's key executives?

Johnson & Johnson's management team includes the folowing people:
  • Mr. Alex Gorsky, Chairman & CEO (Age 59)
  • Mr. Joseph J. Wolk CPA, Exec. VP & CFO (Age 52)
  • Dr. Paulus A. Stoffels, Chief Scientific Officer (Age 57)
  • Mr. Michael H. Ullmann, Exec. VP & Gen. Counsel (Age 60)
  • Mr. Joaquin Duato, Vice Chairman of Exec. Committee (Age 56)

Who are Johnson & Johnson's major shareholders?

Johnson & Johnson's stock is owned by many different of institutional and retail investors. Top institutional shareholders include CIBC Private Wealth Group LLC (0.09%), PGGM Investments (0.08%), Manning & Napier Group LLC (0.08%), DNB Asset Management AS (0.07%), Assenagon Asset Management S.A. (0.06%) and Robeco Institutional Asset Management B.V. (0.06%). Company insiders that own Johnson & Johnson stock include Alex Gorsky, Charles Prince, Joaquin Duato, Marillyn A Hewson, Michael E Sneed, Paulus Stoffels, Peter Fasolo and Ronald A Kapusta. View Institutional Ownership Trends for Johnson & Johnson.

Which institutional investors are selling Johnson & Johnson stock?

JNJ stock was sold by a variety of institutional investors in the last quarter, including Artemis Investment Management LLP, Hexavest Inc., Calamos Advisors LLC, Main Street Research LLC, Factory Mutual Insurance Co., Gateway Investment Advisers LLC, Ellevest Inc. and Robeco Institutional Asset Management B.V.. Company insiders that have sold Johnson & Johnson company stock in the last year include Alex Gorsky, Joaquin Duato, Michael E Sneed, Peter Fasolo and Ronald A Kapusta. View Insider Buying and Selling for Johnson & Johnson.

Which institutional investors are buying Johnson & Johnson stock?

JNJ stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Commerzbank Aktiengesellschaft FI, State of Alaska Department of Revenue, DNB Asset Management AS, Centre Asset Management LLC, Pwmco LLC, PGGM Investments and Beech Hill Advisors Inc.. Company insiders that have bought Johnson & Johnson stock in the last two years include Charles Prince and Marillyn A Hewson. View Insider Buying and Selling for Johnson & Johnson.

How do I buy shares of Johnson & Johnson?

Shares of JNJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Johnson & Johnson's stock price today?

One share of JNJ stock can currently be purchased for approximately $130.00.

How big of a company is Johnson & Johnson?

Johnson & Johnson has a market capitalization of $343.09 billion and generates $81.58 billion in revenue each year. The company earns $15.30 billion in net income (profit) each year or $8.18 on an earnings per share basis. Johnson & Johnson employs 135,100 workers across the globe.View Additional Information About Johnson & Johnson.

What is Johnson & Johnson's official website?

The official website for Johnson & Johnson is http://www.jnj.com/.

How can I contact Johnson & Johnson?

Johnson & Johnson's mailing address is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. The company can be reached via phone at 732-524-0400.


MarketBeat Community Rating for Johnson & Johnson (NYSE JNJ)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  818 (Vote Outperform)
Underperform Votes:  904 (Vote Underperform)
Total Votes:  1,722
MarketBeat's community ratings are surveys of what our community members think about Johnson & Johnson and other stocks. Vote "Outperform" if you believe JNJ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe JNJ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel